David Simel, MD, and William Kim, MD, explore renal cell carcinoma in this JAMA Clinical Review podcast. They discuss key insights from the 2019 Nobel Prize research on…
Advances in non-small cell lung cancer (NSCLC) treatment have transformed care from a one-size-fits-all approach in the 1990s to highly personalized regimens today. Treatment now considers actionable mutations…
A groundbreaking trial in the UK is testing the world’s first “personalized” mRNA vaccine against the deadliest form of skin cancer, melanoma. This innovative vaccine is tailored to…
Michael Hofman, FRACP, MBBS, explores the evolving landscape of imaging techniques in the diagnosis and treatment of renal cell carcinoma, particularly focusing on PET-CT scans. Historically underutilized in…
Learn about the specifics of treating non-small cell lung cancer (NSCLC) when a KRAS mutation is present. The KRAS gene, often mutated in several cancers including NSCLC, signals…
Ed Overfield shares his personal battle with non-small cell lung cancer, a journey marked by the loss of his mother to the same disease and his own diagnosis…
Rajdeep Mysore, MD discusses melanoma, the most dangerous type of skin cancer. Originating from melanocytes, the color-producing cells in the skin, melanomas often appear as black or brown…
Helen Rizos, PhD focuses on the clinical value of cell-free DNA in the management of melanoma. It highlights how circulating tumor DNA can be predictive and prognostic for…
This video shares the journey of how the pap smear, a crucial test for cervical cancer, became a routine part of healthcare for women. It highlights the diverse…
Most vaccines help the immune system learn to identify and fight off harmful viruses or bacteria before someone gets sick. But, scientists are also creating vaccines to treat…
Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer.…
Emma Rossi, MD, a gynecologic oncologist at Duke Health, discusses cervical cancer prevention and HPV. Dr Rossi explains that cervical cancer is the third most common gynecologic cancer…